Lyell Immunopharma
LYEL
LYEL
93 hedge funds and large institutions have $404M invested in Lyell Immunopharma in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 93 → 93 (0)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
51% less capital invested
Capital invested by funds: $823M → $404M (-$419M)
Holders
93
Holding in Top 10
3
Calls
$48K
Puts
$7K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$2.87M | |
| 3 | +$1.53M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.36M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.36M |
Top Sellers
| 1 | -$5.66M | |
| 2 | -$1.16M | |
| 3 | -$1.12M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$886K |
| 5 |
Morgan Stanley
New York
|
-$681K |